Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More Price Transparency, Cost Competition For Surgical Procedures Needed, Experts Tell US Senators

Executive Summary

Lack of transparent pricing for health care services was discussed at a recent Senate committee hearing on high US health-care costs. Fraud and waste of products at hospitals were also on the agenda.

You may also be interested in...



Executive Order Gives HHS Power To Disclose True Device, Procedure Costs To Patients

Despite industry opposition, President Trump signed a cost transparency executive order giving HHS the regulatory power to reveal to the public, health-care facilities’ costs of devices and procedures.

CMS Proposes More Online Transparency For Hospital Charges

The US Centers for Medicare and Medicaid Services is proposing that hospitals make their charges for individual items and services – including bills for advanced imaging scans and anesthesiologists’ charges – available on a searchable website to foster more transparency on specific health-care costs for patients.

Industry Points To Gaps In Study Naming Imaging As Key US Cost Driver

A Harvard study concluded that higher utilization rates for advanced imaging in the US, compared to 10 other wealthy countries with higher life expectancies, help account for America's unnecessarily high spending on medical care. Industry argues the study misrepresents current imaging use.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT122926

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel